Latest

May 18, 2018
Pharmaceutical Executive
By Pharmaceutical Executive Editors
This article is a roundtable consisting of global Medical Affairs leaders to discuss the potential of Medical Affairs as a key value driver and the role MAPS will play in bringing that potential to fruition.
May 14, 2018
After months of expectations and repeated delays, President Trump formally announced his strategy for making prescription medicines more affordable and accessible in the U.S.
May 10, 2018
Pharmaceutical Executive
A variety of consultant options are available to the pharma industry; this article is a 3-step guide to selecting the right consultant.
May 08, 2018
Pharmaceutical Executive
Pharm Exec speaks with Tim Sullivan, who brings that sought-after melding of business and scientific perspectives to his role as chief financial officer for Apellis.
May 05, 2018
Pharmaceutical Executive
Charting the course that has led to payer vertical integration and what it may mean for pharma manufacturers.
May 01, 2018
The recent Pharma Customer Experience Summit explored the changing ways that patients are searching for medical information. Moe Alsumidaie highlights the takeaways.
Apr 30, 2018
CEO Helen Torley talks to Pharm Exec about her vision for Halozyme as a multi-product oncology biotech.
Apr 20, 2018
IFPMA's Thomas Cueni, chair of the AMR Industry Alliance, outlines the critical importance of vaccines in the fight against AMR and infectious diseases.
Apr 15, 2018
We need to look to behavioral science to deconstruct the psychological barriers that make patients act in ways that can seem irrational and self-defeating, writes Jim O'Donoghue.
Apr 11, 2018
Pharmaceutical Executive
This article discusses the supply chain benefits of pharma companies distributing from South Florida.
native1_300x100
lorem ipsum